ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.
RMD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for RMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Resmed Inc ranked in the 27th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Resmed Inc ended up being:
Interest coverage, a measure of earnings relative to interest payments, is 19.16 -- which is good for besting 84.83% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than only 14.56% of the free cash flow producing stocks we're observing.
RMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 44.16% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
IONS, XRAY, JNJ, PKI, and ILMN can be thought of as valuation peers to RMD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Patient monitoring devices in this report refer to the sensors which are used in smart wearable devices. The patient monitoring devices market is driven by increasing demand for wearable for infants and continuously evolving sensor technology. With increasing personal care
The motive of this strategic research report entitled Global Needle Guides Market Which offers company accounts, industry investors, and industry members with consequential insights to enable them to make reliable strategic decisions regarding the opportunities in the global Needle Guides
DUBLIN, Sept. 30, 2020 /PRNewswire/ -- The "High Performance Doors Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The high performance doors market by revenue is expected to grow at a CAGR of approx. 4% and achieve an…
CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- The MIT Leaders for Global Operations (LGO) program announced today that ResMed, a global digital health and connected medical device company, has become the newest member of its industry partnership. This addition brings the partner company…